Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susan J. Westley"'
Autor:
Sandra N. Nowak, Maureen A. Smythe, Robert L Begle, Joan C. Mattson, Mamtha Balasubramaniam, John M. Koerber, Susan J. Westley
Publikováno v:
Annals of Pharmacotherapy. 36:7-11
OBJECTIVE: To evaluate the correlation between clotting time tests and heparin concentration, the correlation between activated clotting time (ACT) and activated partial thromboplastin time (aPTT) results, and to compare the clinical decisions based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda5be46bce4d5cb815b4802a9d0e86a
https://doi.org/10.1345/aph.1a141
https://doi.org/10.1345/aph.1a141
Autor:
Joan C. Mattson, John M. Koerber, Susan J. Westley, Mamtha Balasubramaniam, Maureen A. Smythe
Publikováno v:
Archives of Pathology & Laboratory Medicine. 125:1458-1462
Objective.—To assess the impact of heparin lot on the correlation between heparin concentration and activated partial thromboplastin time (aPTT), the aPTT therapeutic range, and the heparin level. Design.—Retrospective analysis of data from 2 pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::107a8db882b7e8013cd563a79c663805
https://doi.org/10.5858/2001-125-1458-dhl
https://doi.org/10.5858/2001-125-1458-dhl
Autor:
William W. O'Neill, Robert D. Safian, Sandeep Khurana, Gerald C. Timmis, Susan J. Westley, Joan C. Mattson
Publikováno v:
Journal of Laboratory and Clinical Medicine. 130:401-411
Computerized thromboelastography (TEG) was used to study platelet glycoprotein IIb/IIIa function, characterize the consequences of the interaction between polymerizing fibrin and activated platelets, and establish a quantitative assay of platelet fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50019f80682180b65ec39654323f6fab
https://doi.org/10.1016/s0022-2143(97)90040-8
https://doi.org/10.1016/s0022-2143(97)90040-8
Publikováno v:
The Annals of pharmacotherapy. 37(6)
BACKGROUND: The American College of Chest Physicians (ACCP) recommends that the activated partial thromboplastin time (aPTT) therapeutic range for unfractionated heparin be defined as the aPTT corresponding to a heparin concentration of 0.3–0.7 μ/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f2bf8bd55165adf40d03faa51a28502
https://pubmed.ncbi.nlm.nih.gov/12773063
https://pubmed.ncbi.nlm.nih.gov/12773063
Autor:
Maureen A. Smythe, Mamtha Balasubramaniam, Sandra N. Nowak, Susan J. Westley, John M. Koerber, Robert L Begle, Joan C. Mattson
Publikováno v:
American journal of clinical pathology. 115(1)
The objectives of the present study were to evaluate the relationship between heparin concentration and activated partial thromboplastin time (aPTT) results, define a heparin concentration-derived therapeutic range for each aPTT instrument, compare a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97113c44e2dfe26fb200c43bafa71f8
https://pubmed.ncbi.nlm.nih.gov/11190801
https://pubmed.ncbi.nlm.nih.gov/11190801
Autor:
Susan J. Westley, Beverly P. Kershaw, Joan C. Mattson, John M. Koerber, Maureen A. Smythe, Robert L Begle
Publikováno v:
Pharmacotherapy. 19(8)
Study Objective. To determine the correlation between activated clotting time (ACT) or activated partial thromboplastin time (aPTT) and plasma heparin concentration. Design. Two-phase prospective study. Setting. University-affiliated community hospit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6d8a554d9dc05da34be7e4d28992b7
https://pubmed.ncbi.nlm.nih.gov/10453963
https://pubmed.ncbi.nlm.nih.gov/10453963